Butyrylcholinesterase level in poisoned patients with phosphide compounds

Saeed Afzali, Seyed Kazem Taheri, Mohamadali Seifrabiei, Saeed Afzali, Seyed Kazem Taheri, Mohamadali Seifrabiei

Abstract

Background: Metal phosphides are widely used as a rodenticide and insecticide and poisoning with these substances has a very high mortality. The aim of this study was to evaluate the butyrylcholinesterase (BuCh) level in poisoning with metal phosphides.

Methods: In this case series study, 60 poisoned patients with zinc phosphide (ZnP) and aluminum phosphide (ALP) who was admitted to poisoning ward in Hamadan, Iran, enrolled in the study and BuCh level was measured. The sex, age, amount of ingestion, time of consumption, signs and symptoms, ECG and arterial blood gas (ABG) changes and clinical outcomes were evaluated.

Results: Most (58.3%) patients were males, the mean age was 32.76±17.65 years. The average amount of ingestion was 7.5±4.6 and 2.5±2.96 gr for ZnP and ALP, respectively. Most signs and symptoms were hypotension (97%), nausea and vomiting (82%) and abdominal pain (32%). The average amount of BuCh level in all patients was 5163.25±2158.31 U/L, that's while in ZnP and ALP poisoned patients was 5608±1577 U/L and 4721.46±2562U/L respectively. The most dysrhythmia (26.7%) was sinus tachycardia. Acidosis was seen in 33.3% of patients. 14 patients died after hospital admission, which caused a 23.3% fatality rate.

Conclusion: Our results showed that, there was no significant change in BuCh level in poisoned patients with phosphide compounds.

Keywords: Aluminum Phosphide; Butyrylcholinesterase.; Zinc Phosphide.

Conflict of interest statement

The authors have declared no conflicts of interest.

Figures

Figure 1
Figure 1
Mean butyrylcholinesterase level in the participants

References

    1. World Health Organization. Suicide. WHO ; 2018. Available at:
    1. Abder-Rahman HA, Battah AH, Ibraheem YM, Shomaf MS, Ei-Batainch N. Aluminum phosphide fatalities, new local experience. Med Sci Law. 2000;40:164–8.
    1. Bogle RG, Theron P, Brooks P, Dargan PI, Redhead J. Aluminium phosphide poisoning. Emerg Med J. 2006;23:e3.
    1. Gargi J, Rai H, Chanana A, Rai G, Sharma G, Bagga IJ. Current trend of poisoning--a hospital profile. J Indian Med Assoc. 2006;104:72–3.
    1. Goel A, Aggarwal P. Pesticide poisoning. Natl Med J India . 2007;20:182–91.
    1. Murali R, Bhalla A, Singh D, Singh S. Acute pesticide poisoning: 15 years experience of a large North-West Indian hospital. Clin Toxicol (Phila) 2008;47:35–8.
    1. Shadnia S, Sasanian G, Allami P, et al. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol. 2009;28:209–13.
    1. Jain RK, Gouda NB, Sharma VK, et al. Esophageal complications following aluminum phosphide ingestion: an emerging issue among survivors of poisoning. Dysphagia. 2010;25:271–6.
    1. Etemadi-Aleagha A, Akhgari M, Iravani FS. Aluminum phosphide poisoning-related deaths in Tehran, Iran, 2006 to 2013. Medicine (Baltimore) 2015;94:e1637.
    1. Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminium phosphide poisoning. Arch Hyg Toxicol . 2012;63:61–73.
    1. Proudfoot AT. Aluminium and zinc phosphide poisoning. Clin Toxicol. 2009;47:89–100.
    1. Singh S, Bhalla A, Verma SK, Kaur A, Gill K. Cytochrome-C oxidase inhibition in 26 aluminum phosphide poisoned patients. Clin Toxicol. 2006;44:155–8.
    1. Hsu CH, Chi BC, Liu MY, et al. Phosphine-induced oxidative damage in rats: role of glutathione. Toxicology. 2002;179:1–8.
    1. Changal KH, Latief M, Parry M, Abbas F. Aluminium phosphide poisoning with severe cardiac dysfunction and the role of digoxin. BMJ Case Rep. 2017;2017:pii: bcr-2017-220125.
    1. Al-Azzawi M, Al-Hakkak Z, Al-Adhami B. In vitro inhibitory effects of phosphine on human and mouse serum cholinesterase. Toxicol Environmen Chem. 1990;29:53–6.
    1. Mittra S, Peshin SS, Lall SB. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride. Acta Pharmacol Sin. 2001;22:37–9.
    1. Potter WT, Garry VF, Kelly JT, et al. Radiometric assay of red cell and plasma cholinesterase in pesticide appliers from Minnesota. Toxicol Appl Pharmacol. 1993;119:150–5.
    1. Oghabian Z, Afshar A, Rahimi HR. Hepatotoxicity due to zinc phosphide poisoning in two patients: role of N-acetylcysteine. Clin Case Rep . 2016;4:768–72.
    1. Agrawal VK, Bansal A, Singh RK, Kumawat BL, Mahaja P. Aluminum phosphide poisoning: Possible role of supportive measures in the absence of specific antidote. Indian J Crit Care Med. 2015;19:109–12.
    1. Gurjar M, Baronia AK, Azim A, Sharma K. Managing aluminum phosphide poisonings. J Emerg Trauma Shock. 2011;4:378–84.
    1. Chugh SN, Chugh K, Arora V, Kakkar R, Sharma A. Blood catalase levels in acute aluminium phosphide poisoning. J Assoc Physicians India . 1997;45:379–80.
    1. Soltaninejad K, Beyranvand MR, Momenzadeh SA, Shadnia S. Electrocardiographic findings and cardiac manifestations in acute aluminum phosphide poisoning. J Forensic Leg Med. 2012;19:291–3.
    1. Nabih Z, Amiar L, Abidli Z, Windy M, et al. Epidemiology and risk factors of voluntary pesticide poisoning in Morocco (2008-2014) Epidemiol Health. 2017;39:e2017040.
    1. Singh Y, Joshi SC, Satyawali V, Gupta A. Acute aluminium phosphide poisoning, what is new? Egypt J Intern Med. 2014;26:99–103.
    1. Wahab A, Rabbani MU, Wahab S, Khan RA. Spontaneous self-ignition in a case of acute aluminium phosphide poisoning. Am J Emerg Med. 2009;27:752–6.
    1. Bhalla A, Mahi S, Sharma N, Singh S. Polyserositis: an unusual complication of aluminum phosphide poisoning. Asia Pac J Med Toxicol. 2012;1:14–17.
    1. Jha SC, Mukhopadhyay A, Singh BK. A study on cardiac arrhythmia in patients with aluminium phosphide poisoning in North Bihar. J Med Sci Clin Res. 2017;5:24031–4.
    1. Trakulsrichai S, Kosanyawat N, Atiksawedparit P, et al. Clinical characteristics of zinc phosphide poisoning in Thailand. Ther Clin Risk Manag. 2017;13:335–40.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere